| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.05 |